Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by 57% for every ...

This free half-day event will feature three panels of subject matter experts discussing the latest advancements in ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

Teams within the Scientific Tracks will join the ASAP CRN, an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority research ...

There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether sensory impairments, such ...

A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s disease.

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...

Medtronic’s BrainSense aDBS is a therapy intended to improve the quality of life for individuals living with Parkinson’s disease.

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...

A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...